Brief: Fusion Pharmaceuticals Reports Q4 Net Loss Of $0.40 Per Share
17/03/2022 11:14
March 17 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS - EXPECTS CASH, CASH EQUIVALENTS
AND
INVESTMENTS AS OF DEC 31, 2021 WILL ENABLE CO TO FUND OPERATIONS
THROUGH END OF 2023
* FOR Q4 OF 2021, FUSION REPORTED A NET LOSS OF $0.40 PER
SHARE
* Q4 EARNINGS PER SHARE VIEW $-0.47 -- REFINITIV IBES DATA
Source text for Eikon: ID:nPn1jpWD4a
Further company coverage: FUSN.O
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary